CTS implement the Bio-Rad Geenius HIV 1/2 supplemental assay on Monday September 21, 2020. The newly licensed Geenius test is an immunochromatographic assay designed to confirm and differentiate individual antibodies to Human Immunodeficiency Virus Types 1 and 2. The assay will be replacing the HIV-1 Western blot and HIV-2 EIA assays which are performed on samples with a reactive result on a licensed HIV 1/2 screening test.
Read all about it on the Communication page by clicking this link: Communications
The recent communication regarding the recent Anti-SARS-CoV-2 Total assay in Tampa has brought about...
On August 9, 2019, the new CTS Laboratory Information System was successfully implemented in St...
On Wednesday August 15, 2018 at 11:00AM PDT, we will be hosting a webinar regarding the changes to F...
As a service to our partners, CTS provides a copy of all licenses and accreditations on our website....
The new Learning Center website launch today on Monday, March 30, 2020. While the link to the new Le...
CTS will be transitioning to a new sFTP server for clients who send test request and/or receive...